<DOC>
	<DOCNO>NCT02776891</DOCNO>
	<brief_summary>This single center image study investigate use PET 68Ga-citrate patient DLBCL BCLU .</brief_summary>
	<brief_title>A Feasibility Study Gallium-68 Citrate PET Detect Aberrant MYC Protein Expression Diffuse Large B-Cell Lymphoma</brief_title>
	<detailed_description>This single center feasibility image study patient diffuse large B-cell lymphoma ( DLBCL ) B-cell Lymphoma , Unclassifiable feature DLBCL Burkitt 's ( BCLU ) . Study participant undergo PET/MRI whole body 68Ga citrate . The study include least 5 patient double hit lymphoma 5 patient DLBCL additional 5 patient expansion dose level establish . Patients DLBCL include optimal dose level resolution cancer lesion establish .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Burkitt Lymphoma</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<mesh_term>Lymphoma , Large B-Cell , Diffuse</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<mesh_term>Gallium citrate</mesh_term>
	<criteria>1 . Histologically confirm DLBCL BCLU . Double hit lymphoma , define positive cytogenetic/FISH analysis translocation involve myc bcl2 double hit score 2 immunohistochemistry describe Johnson et al . DLBCL without myc translocation overexpression method 2 . Presence palpable radiographically measurable disease least 1.5 cm long dimension . 3 . Available prior CT PET/CT scan do last 8 week comparison 4 . Prior chemotherapy radiation measurable lesion must complete least 14 day prior . 5 . Adequate renal function estimate creatinine clearance ≥50 mL/min ( Cockcroft Gault equation ) 6 . No contraindication MRI ( e.g . pacemaker , aneurysm clip , severe claustrophobia ) 7 . Ability sign studyspecific IRBapproved consent prior study entry . Patients must able willing consent undergo study procedure . 8 . Age ≥18 year old 1 . Any serious and/or unstable preexist medical , psychiatric , medical condition could interfere subject 's safety , provision inform consent , compliance study procedures 2 . Body weight 300 pound 3 . Female patient pregnant breastfeed 4 . Prior MRI gadolinium perform &lt; 24 hour study scan 5 . No red blood cell transfusion iron administration route last 7 day 6 . Prior hypersensitivity intolerance gadolinium gallium citrate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>lymphoma</keyword>
	<keyword>gallium citrate</keyword>
	<keyword>PET</keyword>
</DOC>